STOCK NG REMDESIVIR, TOCILIZUMAB SA BANSA MABABA NA — DOH

Ni Monica N. Ladisla
Source: DOH Pharmaceutical Division
Share on facebook
Facebook
Share on twitter
Twitter
Share on email
Email

Maglalaan umano ng limang milyong karagdagang pondo para sa mga ospital ang Department of Health (DOH) dahil sa bumabang stock ng remdesivir at tocilizumab bunsod ng sunud-sunod na pagtaas ng kaso ng COVID-19 kamakailan.

“The current stocks of remdesivir and tocilizumab are running low. The remaining supplies being used by select hospitals are donations from the WHO,” ayon sa DOH.

Dagdag pa ng DOH, “However, if additional supplies do not arrive and considering the current trend of infection, supplies may only last for another two weeks at most.” 

Matatandaang ayon sa mga naging pagsusuri at pagaaral ng mga eksperto noong nakaraang taon, naging mabisang panlaban ang remdesivir at tocilizumab ng mga pasyenteng nagpositibo sa COVID-19.

Ibinahagi rin ng ahensya na nangangailangan na sila ng karagdagang high flow nasal cannulas (HFNC) upang madagdagan ang 1,318 na kasalukuyang gamit ng mga pampubliko at pribadong ospital sa Metro Manila.

“The Health Facility and Services Development Team have already proposed the inclusion of funding amounting to P1,020,000,000.00 for the procurement of 2,550 units of HFNC under Bayanihan 3,” ulat ng DOH.

Nagbigay rin ng karagdagang 548 milyong piso ang DOH sa Center for Health Development sa Metro Manila, DOH-retained at specialty hospitals, Philippine General Hospital, at sa iba pang health facilities.

Ang pondong  umano ito ay gagamitin sa hiring ng karagdagang 7,613 medical officers, nurses, medical technologists, radiologic technologists, pharmacists, respiratory therapists, nursing attendants, at iba pang allied medical personnel.

CONTACT US

Anchored on its mantra, “Sentro ng Katotohanan, Tapat sa Mamamayan”, Balita Central Digital complements and supports the Balita Central newspaper published bi-monthly to combat fake news and to provide the public with easy-to-digest news bits that are sourced solely from the Presidency and government agencies. 

Balita Central is under the supervision of the Bureau of Communications Services (BCS), one of the attached agencies of the Presidential Communications Operations Office (PCOO).

Launched on February 28, 2019 at the Manila Light Rail Transit System Line 2 (LRT-2) Cubao Station, Quezon City, it also aims to raise awareness among local communities about the policies, programs, and accomplishments of the Presidency. 

Through this platform, Balita Central Digital aims to reach further the online community to deliver more accurate information and communication services in order to educate the citizenry regarding national issues which would enlighten them to be engaged and be empowered in contributing to building a better nation.

Balita Central is situated at the BCS Headquarters located beside the Philippine Cancer Society along San Rafael, San Miguel, Malacañang Complex, Manila City. Its official website address is balitacentral.ph.

For inquiries and feedback, Balita Central may be contacted at editorialdesk.bcs@gmail.com.